Showing results (401-410 of 446) with videos related to

Sort By:
Pageof 45
Bioorganic & Medicinal Chemistry Letters|May 26, 1999
Nonpeptide oxytocin antagonists: analogs of L-371,257 with improved potencyP D Williams, M G Bock, B E Evans, et al.
Frontiers in Immunology|March 27, 2023
Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiativeHector Bonilla, Michael J Peluso, Kathleen Rodgers, et al.
Blood|January 21, 2022
Structural racism is a mediator of disparities in acute myeloid leukemia outcomesIvy Elizabeth Abraham, Garth H Rauscher, Anand Ashwin Patel, et al.
Translational Stroke Research|June 16, 2023
Neutralizing RGMa with Elezanumab Promotes Cerebroprotection and Recovery in Rabbit Middle Cerebral Artery OcclusionPeer B Jacobson, Andrea Mothe, Aharon Levy, et al.
ESMO Open|December 3, 2025
Radiomic signatures to estimate survival in patients with advanced hepatocellular carcinoma treated with sorafenib: Cancer and Leukemia Group B 80802 (Alliance)L Dercle, S Geyer, A B Nixon, et al.
Vaccine|March 13, 2026
2023-2024 COVID-19 vaccination coverage in pregnancy in ten healthcare delivery organizations in the United StatesStephanie A Irving, Bradley Crane, Matthew F Daley, et al.
Obstetrics and Gynecology|June 18, 2026
Association of Respiratory Syncytial Virus Vaccination During Pregnancy With Adverse Obstetric and Neonatal OutcomesMalini DeSilva, Jacob Haapala, Elyse O Kharbanda, et al.
Biochemical Pharmacology|May 31, 2011
Potentiation of analgesic efficacy but not side effects: co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in ratsChang Z Zhu, Chih-Liang Chin, Nathan R Rustay, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2010
Identification of potent, highly constrained CGRP receptor antagonistsCraig A Stump, Ian M Bell, Rodney A Bednar, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2006
Identification of novel, orally bioavailable spirohydantoin CGRP receptor antagonistsIan M Bell, Rodney A Bednar, John F Fay, et al.
Pageof 45